Follow-up and extended follow-up of participants
Ended Awarded Last action
- Contract number
- 75N91018F00002
- Awardee
-
Fundacion Inciensa UEI KDL2VERNRKA5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $55,313,407
Award facts
- Opportunity
-
- N01CP7101582 Solicitation number
- Evaluation of Single Dose Protection Afforded by the Prophylactic HPV Vaccines Award Notice · Posted Dec 23, 2016
- Contract value 100% obligated
- $55,313,407.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541720 Research and Development in the Social Sciences and Humanities
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Sealed Bid
- Pricing
- Firm Fixed Price
- Place of performance
- Costa Rica
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $227,365 | |
| Exercise an Option | $3,125,784 | |
| Exercise an Option | $9,049,004 | |
| Exercise an Option | $9,413,197 | |
| Exercise an Option | $9,349,497 | |
| Funding Only Action | $7,151 | |
| Exercise an Option | $8,646,280 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $8,640,754 | |
| Exercise an Option | $5,364,925 | |
| Original award | $1,489,450 |
Show all 12
About this award
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Fundacion Inciensa, a non-profit organization and foundation based in Costa Rica. The $55,313,407 contract is for follow-up and extended follow-up of participants in an evaluation of the single-dose protection afforded by prophylactic human papillomavirus (HPV) vaccines. The contract has an ultimate completion date of September 15, 2026. Fundacion Inciensa holds a $49 million Indefinite Delivery Contract (IDC) with the NCI, which enables the organization to provide ongoing epidemiological, clinical, and laboratory research services related to cancer, vaccines, and infectious diseases. This specific delivery order under the IDC will support "Epidemiology and Prevention of Infections and Related Diseases" efforts through September 2024, with potential for additional task orders. The contract has no set-aside designation.
Quick answers
Who was awarded contract 75N91018F00002?
75N91018F00002 was awarded to Fundacion Inciensa by National Cancer Institute (National Institutes of Health) on April 6, 2018.
How much is contract 75N91018F00002 worth?
The government has obligated $55,313,407 on 75N91018F00002.
Is contract 75N91018F00002 an order under another contract?
Yes. 75N91018F00002 is a delivery order under HHSN261201700012I, an indefinite delivery contract.
Was contract 75N91018F00002 competed?
The extent of competition for 75N91018F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award